Board of Directors
The PMC board of directors is dedicated to supporting the Coalition’s work to promote the understanding and adoption of personalized medicine concepts, services, and products.
Gabriele Allegri, M.B.A.
Commercial Head, Precision Medicine, Johnson & Johnson Innovative Medicines
Antonio L. Andreu, M.D., Ph.D.
Scientific Director, EATRIS (European Infrastructure for Translational Medicine)
Lori Frank, Ph.D.
Senior Vice President, Research, Policy, and Programs, New York Academy of Medicine
Anne-Marie Martin, Ph.D.
Senior Vice President & Global Head, Experimental Medicine, GlaxoSmithKline
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center
Jay G. Wohlgemuth, M.D.
Former Chief Medical Officer & Chief Scientific Officer, Quest Diagnostics; Managing Partner, Trusted Health Advisors
